Drug
ZL 1109
ZL 1109: highest development phase Phase 3, developed by Zai Lab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZL-1109 (VRDN-003) NCT07211776 | Phase 3 | Thyroid Eye Disease (TED) |
Latest
No recent events.
Follow ZL 1109 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.